drugset / Trial / NCT00471393

Topical Diclofenac Efficacy in Symptomatic Relief of Temporomandibular Degenerative Joint Disease

NCT00471393

Completed 28 enrolled University of Alberta
RandomizedParallel-groupDouble-blindTreatment

Summary

The use of a topical medication was compared to placebo to be applied over the symptomatic temporomandibular joint in women with the diagnosis of osteoarthritis of the temporomandibular joint(s). The hypothesis is to investigate whether the use of a topical anti-inflammatory medication when compared to the placebo would decrease the pain of the affected joint and/or increased mouth opening.

Timeline

Start
2006-05
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 1.5 % Topical

Indications